Recently, it was reported that TAM may be the predominant source of LPA production in the ascites of ovarian cancer patients via a consecutive action by platelet-activating factor acetylhydrolase (PAF-AH) and ATX [12]. This evidence concerns the gene ENPP2 and ovarian cancer.